Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kristina Luebbe"'
Autor:
W Siggelkow, Iris Schrader, Thilo Dörk, Peter Hillemanns, E Kuehnle, K-H Noeding, Kristina Luebbe, T Noesselt, P Kaur, TW Park-Simon, Christoph Uleer, M Arfsten, C Busch, N Krentel, S Noeding
Publikováno v:
Cancer Research. 79:P1-15
Introduction Controversy exists with regards to the optimal regimen for neoadjuvant chemotherapy (NAC) of TNBC. Platinum-based regimens seem to be more active in TNBC improving pCR rates significantly. But adding platinum to an anthracycline/taxane c
Autor:
Hermann Wiebringhaus, Michael Untch, S. Loibl, Claus Hanusch, S. Kuemmel, G. von Minckwitz, Marianne Just, C Denkert, J-U Blohmer, J Jackisch, Michael R. Clemens, Andreas Schneeweiss, Knut Engels, John Hackmann, Valentina Nekljudova, Kristina Luebbe, Bahriye Aktas, Christian Schem, M. Warm, Sabine Schmatloch
Publikováno v:
Cancer Research. 77:P4-21
Background Our recent randomized, multicenter phase III GeparSepto study (Untch M et al. Lancet Oncol 2016) found that substituting nab-paclitaxel for standard solvent-based paclitaxel significantly improved the pathologic complete response (pCR) rat
Autor:
S Lemster, E Kuehnle, M Arfsten, Kristina Luebbe, C Busch, T Doerk, W Siggelkow, P Hillemans, T Oeztuerk, A Moser, J John, T Noesselt, TW Park-Simon, S Noeding
Publikováno v:
Cancer Research. 77:P5-10
Introduction Although the health of immigrants is an important issue in national health care policy there is a serious shortage of data in many countries. Most studies lack information on educational status which is a major limitation. In this prospe
Autor:
Thomas Decker, Nicole Burchardi, Jenny Furlanetto, Kristina Luebbe, E Senkus-Konefka, A-C. Hardy-Bessard, Sabine Seiler, Volkmar Mueller, Karen A. Gelmon, Carlo Palmieri, Mathias Uhlig, C Denkert, S. Loibl, G. von Minckwitz, Christoph Mundhenke, Martina Schmidt, Francesco Cognetti, Marc Thill, Jana Barinoff
Publikováno v:
Cancer Research. 78:OT3-05
Background: Although endocrine therapy (ET) is recommended as first-line therapy for hormone receptor (HR)-positive, HER2-negative metastatic breast cancer (MBC) up to 50% of patients receive chemotherapy in this setting. Meanwhile new targeted treat
Autor:
T Noesselt, Thilo Dörk, Peter Hillemanns, S Noeding, Iris Schrader, W Siggelkow, E Kühnle, TW Park-Simon, Kristina Luebbe, M Arfsten, KH Noeding
Publikováno v:
Geburtshilfe und Frauenheilkunde.
Autor:
Esther Pohl-Rescigno, Eric Hahnen, Claus Hanusch, Volker Möbus, Nana Weber-Lassalle, Peter A. Fasching, Rita K. Schmutzler, Hans Tesch, Michael Untch, Jan Hauke, Carsten Denkert, Jenny Furlanetto, Bianca Lederer, Andreas Schneeweiss, Sibylle Loibl, Volkmar Müller, Valentina Nekljudova, Kristina Luebbe, Kerstin Rhiem, Christian Jackisch
Publikováno v:
Journal of Clinical Oncology. 37:573-573
573 Background: GeparOcto compared the efficacy of two neoadjuvant treatment (NAT) regimens in high-risk early breast cancer (BC): Sequential intense dose-dense epirubicin, paclitaxel, and cyclophosphamide (iddEPC) and weekly paclitaxel plus non-pegy
Autor:
Hans Tesch, Claus Hanusch, Nana Weber-Lassalle, Volker Moebus, Valentina Nekljudova, Kristina Luebbe, Rita K. Schmutzler, Kerstin Rhiem, Jenny Furlanetto, Esther Pohl, S. Loibl, B. Lederer, Andreas Schneeweiss, Michael Untch, Carsten Denkert, C. Jackisch, Peter A. Fasching, Eric Hahnen, Jan Hauke, Volkmar Müller
Publikováno v:
Annals of Oncology. 29:viii77
Autor:
Kristina Luebbe, Karl-Heinz Noeding, Wulf Siggelkow, Iris Schrader, Christoph Busch, Peter Hillemanns, Thilo Dörk, Tjoung-Won Park-Simon, T Noesselt, Momme Arfsten, Regina Meier, Stefanie Noeding, Elna Kuehnle
Publikováno v:
Journal of Clinical Oncology. 36:e18650-e18650
e18650Background: Although immigrant health is an important issue in worldwide health policy there is a serious shortage of data in many countries, especially survival data. In this prospective cro...
Autor:
Jana Barinoff, Thomas Decker, Jenny Furlanetto, Mathias Uhlig, Nicole Burchardi, Sibylle Loibl, Volkmar Mueller, Kristina Luebbe, Gunter von Minckwitz, Marc Thill, Marcus Schmidt, Sabine Seiler, Carsten Denkert, Christoph Mundhenke
Publikováno v:
Journal of Clinical Oncology. 35:TPS1115-TPS1115
TPS1115 Background: Although endocrine based therapy is recommended as first-line treatment in metastatic breast cancer (MBC) in patients with an HER2-/HR+ tumour up to 50% of the patients receive chemotherapy. Palbociclib (P) a CDK4/6 inhibitor impr
Autor:
Momme Arfsten, Peter Hillemanns, T Noesselt, Stefanie Noeding, Iris Schrader, Tjoung-Won Park-Simon, Elna Kuehnle, Thilo Dörk, Alexander Moser, Wulf Siggelkow, Jutta John, Kristina Luebbe
Publikováno v:
Journal of Clinical Oncology. 35:e18132-e18132
e18132 Background: In 2003 the German Cancer Society and the German Society for Breast Disease introduced a number of Quality Indicators (QIs) to improve standards of breast cancer care. Although QIs should be based on clinical evidence, evidence for